|
🐜
|
Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity
9 auth.
Debatosh Majumdar,
Kyung-Ho Jung,
Hongzhen Zhang,
S. Nannapaneni,
Xu Wang,
A. Amin,
...
Zhengjia Chen,
Z. Chen,
D. Shin
|
7 |
2014 |
7
🐜
|
|
🐜
|
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
11 auth.
M. Rahman,
A. Amin,
Dongsheng Wang,
Lydia Koenig,
S. Nannapaneni,
Zhengjia Chen,
...
Zhibo Wang,
G. Sica,
Xingming Deng,
Z. Chen,
D. Shin
|
6 |
2013 |
6
🐜
|
|
🐜
|
Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.
12 auth.
M. Rahman,
Pengfei Wang,
Zhixiang Zhao,
Dongsheng Wang,
S. Nannapaneni,
Chao Zhang,
...
Zhengjia Chen,
Christopher C. Griffith,
S. Hurwitz,
Z. Chen,
Yonggang Ke,
D. Shin
|
6 |
2017 |
6
🐜
|
|
🐜
|
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.
14 auth.
M. Rahman,
A. Amin,
Xu Wang,
J. Zuckerman,
C. H. J. Choi,
Bingsen Zhou,
Dongsheng Wang,
S. Nannapaneni,
Lydia Koenig,
Zhengjia Chen,
...
Z. Chen,
Y. Yen,
Mark E. Davis,
D. Shin
|
6 |
2012 |
6
🐜
|
|
🐜
|
Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study
22 auth.
N. Saba,
S. Hurwitz,
S. Kono,
Chung S. Yang,
Yang Zhao,
Zhengjia Chen,
G. Sica,
S. Müller,
Rachel Moreno-Williams,
Melinda Lewis,
...
William L. Grist,
Amy Y. Chen,
C. Moore,
T. Owonikoko,
Suresh R Ramalingam,
J. Beitler,
S. Nannapaneni,
H. Shin,
J. Grandis,
F. Khuri,
Z. Chen,
D. Shin
|
5 |
2013 |
5
🐜
|
|
🐜
|
Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma
18 auth.
N. Jiang,
Dongsheng Wang,
Zhongliang Hu,
H. Shin,
G. Qian,
M. Rahman,
Hongzhen Zhang,
A. Amin,
S. Nannapaneni,
Xiaojing Wang,
...
Zhengjia Chen,
G. Garcia,
G. MacBeath,
D. Shin,
F. Khuri,
Jun Ma,
Z. Chen,
N. Saba
|
5 |
2014 |
5
🐜
|
|
🐜
|
HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models
15 auth.
Dongsheng Wang,
G. Qian,
Hongzhen Zhang,
K. Magliocca,
S. Nannapaneni,
A. Amin,
M. Rossi,
Mihir R Patel,
M. El-Deiry,
J. Wadsworth,
...
Zhengjia Chen,
F. Khuri,
D. Shin,
N. Saba,
Z. Chen
|
5 |
2016 |
5
🐜
|
|
🐜
|
Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies
20 auth.
D. Shin,
Hongzhen Zhang,
N. Saba,
Amy Y. Chen,
S. Nannapaneni,
A. Amin,
S. Müller,
Melinda Lewis,
G. Sica,
S. Kono,
...
J. Brandes,
W. Grist,
Rachel Moreno-Williams,
J. Beitler,
S. Thomas,
Zhengjia Chen,
H. Shin,
J. Grandis,
F. Khuri,
Z. Chen
|
5 |
2013 |
5
🐜
|
|
🐜
|
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
13 auth.
Jing Xu,
S. Müller,
S. Nannapaneni,
L. Pan,
Yuxiang Wang,
Xiang-hong Peng,
Dongsheng Wang,
M. Tighiouart,
Zhengjia Chen,
N. Saba,
...
J. Beitler,
D. Shin,
Z. Chen
|
5 |
2012 |
5
🐜
|
